Breaking New Ground with Digital Biomarkers (IQVIA)
Hamburg (Germany), March 15, 2022: With the relentless rise of digital health, we are witnessing the emergence of digital biomarkers – novel, objective and quantifiable, patient-generated measures of physiology, behaviour, cognitive function and mood that are captured via connected digital devices.
This whitepaper outlines how digital biomarkers generate novel insights and increase health outcomes in clinical research and clinical practice in the fields of patient recruitment, risk stratification, and decentralized virtual clinical trials in drug development with new engagement models.
Source: Breaking New Ground with Digital Biomarkers (IQVIA). IQVIA. 2021.